20 research outputs found

    Box plots for cytokine positive T cell frequencies on stimulation with CSP peptides pre-vaccination, 1 month after the last vaccination and 12 months after the last vaccination, shown by cytokine and by vaccination group.

    No full text
    <p>Box plots show medians and inter-quartile ranges, the whiskers show 5<sup>th</sup> to 95<sup>th</sup> centiles, and outliers are shown by circles. Vaccination group is indicated by “RTS” for RTS,S/AS01<sub>E</sub> and “Ctl” for rabies control. T cell phenotype is indicated by + and − for the cytokines shown far left. Significance is indicated by a horizontal line at p<0.0003 (using a Bonferroni correction for multiple comparisons).</p

    A representative example of the identification and quantitation of RTS,S/AS01<sub>E</sub> induced CSP-peptide reactive CD4+ T cells producing various cytokines.

    No full text
    <p>A) CD4+/CD8+ T cells were gated off the side scatter (SCC) Vs CD3 gate, after gating on lymphocytes on the SSC vs forward scatter (FSC) density plot. B) Determination of the percentages of IL2+, TNF+ and IFNγ CD4+ T cells following <i>in vitro</i> stimulations with nothing (Media control), CSP and SEB. C) An example of a typical gating tree showing the identification and quantitation of CD4+ T cells producing various combinations of IL2, TNF and IFNγ, following stimulation with nothing (media control), CSP or SEB, is shown. The resultant data was expressed as percentages of cytokine positive CD4+ T cells.</p

    Kaplan Meier plot showing fraction of the RTS,S/AS01<sub>E</sub> vaccinees experiencing an episode of clinical malaria, divided according to antibody and TNF+ only CD4+ cell anti-CSP responses.

    No full text
    <p>The 4 groups are as follows; 1) anti-CSP antibody titers below 40 EU/ml, TNF+ only CD4+ cells on CSP stimulation below median; 2) anti-CSP antibody titers above 40 EU/ml, TNF+ only CD4+ cells on CSP-peptide stimulation below median; 2) anti-CS antibody titers below 40 EU/ml, TNF+ CD4+ cells on CSP-peptide stimulation above median; 2) anti-CSP antibody titers above 40 EU/ml, TNF+ only CD4+ cells on CSP-peptide stimulation above median. The anti-CSP antibody titers are applied as a time-varying covariate.</p

    Hazard Ratios (HR) and 95% Confidence intervals from Cox regression models for the effect of CD4+ cellular responses to CSP on clinical malaria episodes.

    No full text
    <p>Hazard Ratios are adjusted by age (as a continuous variable), distance from the dispensary (continuous variable), bednet use, location of residence (in 4 groupings) and, when all vaccinees are included in an analysis, by vaccination group.</p><p>“At least TNF+” refers to all cells producing TNF, including polyfunctional cells (i.e. producing TNF with IL2, TNF with IFNγ, or TNF with IFNγ and IL2). The parallel definition applies to “at least IL2+”. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0052870#s2" target="_blank">Results</a> that are significant after a Bonferroni correction (i.e.<0.002) are shown in bold.</p
    corecore